Literature DB >> 33258304

Pachychoroid spectrum disease.

Shyamanga Borooah1,2,3, Peng Yong Sim2,4, Sumita Phatak2, Gabriella Moraes2, Chris Yang Wu1, Chui Ming Gemmy Cheung5, Bishwanath Pal2, Dhiren Bujarborua6.   

Abstract

Recent improvements in ophthalmic imaging have led to the identification of a thickened choroid or pachychoroid to be associated with a number of retinal diseases. The number of conditions linked to this phenotype has continued to widen with specific endophenotypes found within the pachychoroid spectrum. The spectrum includes choroidal features such as focal or diffuse choroidal thickening and thinning of the overlying inner choroid, and choroidal hyperpermeability as demonstrated by indocyanine green angiography. In addition, these diseases are associated with overlying retinal pigmentary changes and retinal pigment epithelial dysfunction and may also be associated with choroidal neovascularization. This article provides a comprehensive review of the literature looking at diseases currently described within the pachychoroid spectrum including central serous chorioretinopathy, pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization, peripapillary pachychoroid disease and focal choroidal excavation. We particularly focus on clinical imaging, genetics and pathological findings in these conditions with the aim of updating evidence suggesting a common aetiology between diseases within the pachychoroid spectrum.
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  central serous chorioretinopathy; focal choroid excavation; pachychoroid; pachychoroid neovasculopathy; pachychoroid pigment epitheliopathy; peripapillary pachychoroid disease; polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization

Mesh:

Year:  2020        PMID: 33258304     DOI: 10.1111/aos.14683

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  15 in total

1.  [Are "pachychoroid spectrum disorders" a topic for CME?]

Authors:  H Helbig; F Grehn; W A Lagrèze; U Pleyer; B Seitz
Journal:  Ophthalmologe       Date:  2021-08-05       Impact factor: 1.059

2.  Evaluation of the choroidal vascularity index after subthreshold yellow laser treatment in the patients with chronic central serous chorioretinopathy.

Authors:  Sema Tamer Kaderli; Aylin Karalezli; Ahmet Kaderli; Simay Can Taskin; Sabahattin Sul
Journal:  Eye (Lond)       Date:  2022-05-13       Impact factor: 4.456

3.  Imaging Characteristics of Neovascular and Atrophic Pachychoroidal Spectrum Diseases.

Authors:  Rui Hua; Meixia Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-04

4.  Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up.

Authors:  Jiyang Tang; Xinyao Han; Ran Tang; Mengyang Li; Zongyi Wang; Mingwei Zhao; Jinfeng Qu
Journal:  BMC Ophthalmol       Date:  2022-06-21       Impact factor: 2.086

5.  Multimodal Imaging of Subfoveal Pachydrusen Containing a Blood Flow Signal.

Authors:  Naoko Ishiguro; Takaaki Hayashi; Yoshiko Yamawaki; Kei Mizobuchi; Tsutomu Yasukawa; Shigeru Honda; Tadashi Nakano
Journal:  Case Rep Ophthalmol Med       Date:  2022-06-08

6.  Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.

Authors:  Jihyun Yoon; Wontae Yoon; Seung Kwan Na; Jihyun Lee; Chul Gu Kim; Jong Woo Kim; Han Joo Cho
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

7.  Risk factors and characteristics of central serous chorioretinopathy with later development of macular neovascularisation detected on OCT angiography: a retrospective multicentre observational study.

Authors:  Xiaoyin Zhou; Yuki Komuku; Takashi Araki; Hiroto Terasaki; Akiko Miki; Soichiro Kuwayama; Tomo Nishi; Takamasa Kinoshita; Fumi Gomi
Journal:  BMJ Open Ophthalmol       Date:  2022-04

8.  Evaluation of the Effect of a Novel β3-Adrenergic Agonist on Choroidal Vascularity.

Authors:  Murat Topcuoglu; Fatih Aslan
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

Review 9.  Central Serous Chorioretinopathy and Personality Characteristics: A Systematic Review of Scientific Evidence over the Last 10 Years (2010 to 2020).

Authors:  Giovanni Genovese; Alessandro Meduri; Maria Rosaria Anna Muscatello; Sebastiano Gangemi; Clemente Cedro; Antonio Bruno; Pasquale Aragona; Gianluca Pandolfo
Journal:  Medicina (Kaunas)       Date:  2021-06-16       Impact factor: 2.430

Review 10.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.